Saturday, April 14, 2018 7:36:25 AM
April 23, SEC case expected to be tossed.
May 9 Tentative FDA meeting.
Q1 (May15) 100k-200k units not surprised by an even higher number.
Sometime in June/July we’ll hear the results of both the SEC hearing and the FDA additional clearances announcement(s).
Q2 (Aug 15) sales of near 1M.
Then I expect HUGE numbers to start rolling in because France & Germany are already in motion and we haven’t heard boo about the USA market yet. This is mainly overseas.
I’m not going to get too far ahead of myself, because there isn’t any news to report YET. Many potential deals probably pending our additional clearances.
So I think mid term .03 - .05 is easily justified without any PE ratios needed.
The main thing you may need to do is consider that most CHRONIC pain users will use more than 1 unit at a time. I wear between 2 and 4 units pretty regularly. And how many times are they reloading, 3x a year? 5x? 8x?
Just my 2 cents
My comments above are simply my opinion and nothing more.
I'm enthusiastic at times however I am NOT a professional trader.
Please contact your financial consultant for investment advise.
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM